Skip to main content
Figure 3 | Arthritis Research & Therapy

Figure 3

From: Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden

Figure 3

Adherence to therapy for patients treated with infliximab. The level of adherence to therapy is shown as the fraction (between 1 and 0) of patients remaining on therapy during the observation period. Withdrawal due to any reason (a), adverse events (b), or failure to treatment (c) is presented separately. The number of patients under observation at each time point is listed at the bottom of the figure. DMARD, disease-modifying antirheumatic drug.

Back to article page